TREATMENT OUTCOMES OF LOCALLY ADVANCED OROPHARYNGEAL CANCER: A COMPARATIVE STUDY OF COMBINED MODALITY RADIO-CHEMOTHERAPY VERSUS TWO VARIANTS OF SINGLE MODALITY ALTERED FRACTIONATION RADIOTHERAPY

被引：0
|
作者：
Kader, H. [1 ]
Mydin, A. [1 ]
Alexander, C. [1 ]
Wilson, M. [2 ]
Larsson, S. [1 ]
机构：
[1] BC Canc Agcy, Vancouver Isl Ctr, Radiat Oncol, Vancouver, BC, Canada
[2] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2010年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
978
引用
收藏
页码：S334 / S335
页数：2
相关论文
共 44 条
  • [41] Trial in progress: Open-label, randomized, comparative phase 2/3 study of combination immunotherapy plus standard-of-care chemotherapy and SBRT versus standard-of-care chemotherapy for the treatment of locally advanced or metastatic pancreatic cancer.
    Seery, Tara Elisabeth
    Nangia, Chaitali Singh
    Sender, Leonard S.
    Reddy, Sandeep K.
    Soon-Shiong, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [42] Naive indirect treatment comparison of PanCO, a pilot study of OncoSil P-32 microparticles combined with gemcitabine plus nab-paclitaxel or FOLFIRINOX chemotherapy versus standard-of-care treatment in unresectable locally advanced pancreatic cancer
    Allerdice, S.
    Wilson, N.
    Turner, D.
    McCloud, P.
    Kenny, D.
    Cowley, A.
    Taylor, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S174 - S175
  • [43] Effectiveness and safety of rectal arterial infusion chemotherapy combined with anti-PD1 antibody for microsatellite stable locally advanced rectal cancer: Early outcome report of a two-stage, single armed, phase II study (RAIC)
    Jiao, Y.
    Li, J.
    Kong, X.
    Liu, C.
    Han, S.
    Wang, L.
    Hu, Y.
    Hu, H.
    Song, Y.
    Wang, Z.
    He, J.
    Deng, Q.
    Cao, H.
    Ding, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S433 - S433
  • [44] A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)
    Inhestern, J.
    Schmalenberg, H.
    Dietz, A.
    Rotter, N.
    Maschmeyer, G.
    Jungehuelsing, M.
    Grosse-Thie, C.
    Kuhnt, T.
    Goerner, M.
    Sudhoff, H.
    Wittekindt, C.
    Guntinas-Lichius, O.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 1917 - 1922
12345